• Abbott to acquire Cephea Valve Technologies, Inc. pharma
    January 17, 2019
    Abbott (NYSE: ABT) announced today that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacement technology for people with mitral valve disease.
PharmaSources Customer Service